Extracellular Vesicles in Cancer Progression: From Basic Analysis to Translational Research
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 2353
Special Issue Editor
Interests: exosomes; extracellular vesicles; metastasis; tumour immunity; liquid biopsy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Extracellular vesicles (EVs) are a heterogenous group of membrane-bound vesicles secreted by cells across all living kingdoms. They take part in cell-to-cell communication, and the mechanisms, messages and efficiency of this exchange system are currently under extensive investigation as they are involved in multiple physiological as well as pathological processes.
Remarkably, EV secretion appears to be augmented in tumor cells and has a relevant role in cancer progression, offering a highly effective way to modulate the tumor microenvironment, contributing to the formation of pre-metastatic and metastatic niches and participating in the tumor–immune landscape cross-talk.
This Special Issue of Cancers seeks original articles and review manuscripts focused on (1) analyzing tumor EV cargo, (2) EV function in tumor–microenvironment interplay, (3) the role as modulators of pre-metastatic and metastatic niches across cancer types, (4) EVs’ influence on immune surveillance against tumors and finally (5) EV-based biomarkers and therapeutic development in cancer research.
Dr. Susana García-Silva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- cancer progression
- tumor microenvironment
- tumor–immune landscape cross-talk pre-metastatic and metastatic niches
- immune surveillance
- EV-based biomarkers
- EV-based therapeutic development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
